Literature DB >> 1692551

Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells.

F Sessa1, M Bonato, B Frigerio, C Capella, E Solcia, M Prat, J Bara, I M Samloff.   

Abstract

It has been found by immunohistochemical staining that antigens normally found in gastric and/or intestinal epithelial cells are expressed in most differentiated duct cell carcinomas of the pancreas. Among 88 such tumors, 93% and 92%, respectively, expressed M1 and cathepsin E, markers of gastric surface-foveolar epithelial cells, 51% expressed pepsinogen II, a marker of gastroduodenal mucopeptic cells, 48% expressed CAR-5, a marker of colorectal epithelial cells, and 35% expressed M3SI, a marker of small intestinal goblet cells. Most of the tumors also expressed normal pancreatic duct antigens; 97% expressed DU-PAN-2, and 59% expressed N-terminus gastrin-releasing peptide. In agreement with these findings, electron microscopy revealed malignant cells with fine structural features of gastric foveolar cells, gastric mucopeptic cells, intestinal goblet cells, intestinal columnar cells, pancreatic duct epithelial cells, and cells with features of more than one cell type. Normal pancreatic duct epithelium did not express any marker of gastrointestinal epithelial cells, whereas such benign lesions as mucinous cell hypertrophy and papillary hyperplasia commonly expressed gut-type antigens but rarely expressed pancreatic duct cell markers. By contrast, lesions characterized by atypical papillary hyperplasia commonly expressed both gastric and pancreatic duct cell markers. Metaplastic pyloric-type glands expressed pepsinogen II and, except for their expression of cathepsin E, were indistinguishable from normal pyloric glands. In marked contrast, the immunohistochemical and ultrastructural features of 14 ductuloacinar cell tumors were those of cells lining terminal ductules, centroacinar cells, and/or acinar cells; none expressed any gut-type antigen. The results indicate that gastrointestinal differentiation is common in both benign and malignant lesions of pancreatic duct epithelium and suggest that duct cell carcinomas are histogenetically related to gastric- and intestinal-type metaplastic changes of epithelial cells lining the main and interlobular ducts of the pancreas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692551     DOI: 10.1016/0016-5085(90)91104-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench.

Authors:  David E Rosow; Andrew S Liss; Oliver Strobel; Stefan Fritz; Dirk Bausch; Nakul P Valsangkar; Janivette Alsina; Birte Kulemann; Joo Kyung Park; Junpei Yamaguchi; Jennifer LaFemina; Sarah P Thayer
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

2.  Genetics and pathology of pancreatic cancer.

Authors:  Jordan M Winter; Anirban Maitra; Charles J Yeo
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia.

Authors:  Oliver Strobel; David E Rosow; Elena Y Rakhlin; Gregory Y Lauwers; Amanda G Trainor; Janivette Alsina; Carlos Fernández-Del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

4.  Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation.

Authors:  Katie Partyka; Kevin A Maupin; Randall E Brand; Brian B Haab
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

5.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.

Authors:  Maria Caruso; James Moore; Gregory J Goodall; Michelle Thomas; Stuart Phillis; Anna Tyskin; Glenice Cheetham; Nancy Lerda; Hiroyuki Takahashi; Andrew Ruszkiewicz
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

6.  Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.

Authors:  N Ohike; A Jürgensen; M Pipeleers-Marichal; G Klöppel
Journal:  Virchows Arch       Date:  2003-02-06       Impact factor: 4.064

7.  Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing.

Authors:  G Finzi; M Cornaggia; C Capella; R Fiocca; F Bosi; E Solcia; I M Samloff
Journal:  Histochemistry       Date:  1993-03

8.  Effects of VIP on the regulation of mucin secretion in cultured human pancreatic cancer cells (Capan-1).

Authors:  E Hollande; M Fanjul; S Claret; M E Forgue-Lafitte; J Bara
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

9.  Neoplastic endocrine differentiation of pancreatic ductal adenocarcinoma in a metastatic lymph node: report of a case.

Authors:  Tomotaka Akatsu; Kaori Kameyama; Yuki Nogami; Shigeyuki Kawachi; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

10.  Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.

Authors:  A Hoorens; N R Lemoine; E McLellan; T Morohoshi; T Kamisawa; P U Heitz; B Stamm; J Rüschoff; B Wiedenmann; G Klöppel
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.